X-32697907-G-T

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_StrongBP6BS2_Supporting

The NM_004006.3(DMD):​c.923C>A​(p.Thr308Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000141 in 1,207,836 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 4 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T308I) has been classified as Benign.

Frequency

Genomes: 𝑓 0.000081 ( 0 hom., 1 hem., cov: 22)
Exomes 𝑓: 0.0000073 ( 0 hom. 3 hem. )

Consequence

DMD
NM_004006.3 missense

Scores

1
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:4B:1

Conservation

PhyloP100: 2.82

Publications

2 publications found
Variant links:
Genes affected
DMD (HGNC:2928): (dystrophin) This gene spans a genomic range of greater than 2 Mb and encodes a large protein containing an N-terminal actin-binding domain and multiple spectrin repeats. The encoded protein forms a component of the dystrophin-glycoprotein complex (DGC), which bridges the inner cytoskeleton and the extracellular matrix. Deletions, duplications, and point mutations at this gene locus may cause Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD), or cardiomyopathy. Alternative promoter usage and alternative splicing result in numerous distinct transcript variants and protein isoforms for this gene. [provided by RefSeq, Dec 2016]
DMD Gene-Disease associations (from GenCC):
  • Becker muscular dystrophy
    Inheritance: XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet
  • dilated cardiomyopathy 3B
    Inheritance: XL Classification: DEFINITIVE Submitted by: Ambry Genetics
  • Duchenne and Becker muscular dystrophy
    Inheritance: XL Classification: DEFINITIVE Submitted by: Myriad Women’s Health
  • Duchenne muscular dystrophy
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • progressive muscular dystrophy
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • symptomatic form of muscular dystrophy of Duchenne and Becker in female carriers
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.054557025).
BP6
Variant X-32697907-G-T is Benign according to our data. Variant chrX-32697907-G-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 497518.
BS2
High AC in GnomAd4 at 9 XL,AD gene. Variant has AC lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DMDNM_004006.3 linkc.923C>A p.Thr308Asn missense_variant Exon 9 of 79 ENST00000357033.9 NP_003997.2 P11532

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DMDENST00000357033.9 linkc.923C>A p.Thr308Asn missense_variant Exon 9 of 79 1 NM_004006.3 ENSP00000354923.3 A0A075B6G3

Frequencies

GnomAD3 genomes
AF:
0.0000723
AC:
8
AN:
110613
Hom.:
0
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.000230
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000189
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000276
AC:
5
AN:
181050
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.000307
Gnomad AMR exome
AF:
0.0000367
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000729
AC:
8
AN:
1097167
Hom.:
0
Cov.:
30
AF XY:
0.00000827
AC XY:
3
AN XY:
362755
show subpopulations
African (AFR)
AF:
0.0000379
AC:
1
AN:
26370
American (AMR)
AF:
0.0000285
AC:
1
AN:
35102
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19353
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30163
South Asian (SAS)
AF:
0.00
AC:
0
AN:
53957
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40481
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4134
European-Non Finnish (NFE)
AF:
0.00000713
AC:
6
AN:
841552
Other (OTH)
AF:
0.00
AC:
0
AN:
46055
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000813
AC:
9
AN:
110669
Hom.:
0
Cov.:
22
AF XY:
0.0000304
AC XY:
1
AN XY:
32937
show subpopulations
African (AFR)
AF:
0.000263
AC:
8
AN:
30442
American (AMR)
AF:
0.00
AC:
0
AN:
10318
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2624
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3477
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2604
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5948
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
216
European-Non Finnish (NFE)
AF:
0.0000189
AC:
1
AN:
52848
Other (OTH)
AF:
0.00
AC:
0
AN:
1510
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
1
Bravo
AF:
0.0000529
ESP6500AA
AF:
0.000522
AC:
2
ESP6500EA
AF:
0.000149
AC:
1
ExAC
AF:
0.0000330
AC:
4

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:4Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:2
Oct 04, 2016
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 27, 2019
Revvity Omics, Revvity
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Duchenne muscular dystrophy;C0878544:Cardiomyopathy;C0917713:Becker muscular dystrophy;na:Dystrophin deficiency Uncertain:1
Apr 25, 2020
Natera, Inc.
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Duchenne muscular dystrophy Uncertain:1
Nov 27, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces threonine, which is neutral and polar, with asparagine, which is neutral and polar, at codon 308 of the DMD protein (p.Thr308Asn). This variant is present in population databases (rs145064612, gnomAD 0.02%). This missense change has been observed in individual(s) with DMD-related conditions (internal data). ClinVar contains an entry for this variant (Variation ID: 497518). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt DMD protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Cardiovascular phenotype Benign:1
Jan 29, 2024
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.089
BayesDel_addAF
Benign
-0.52
T
BayesDel_noAF
Benign
-0.68
CADD
Benign
19
DANN
Benign
0.97
DEOGEN2
Benign
0.23
.;T;.;.;T
FATHMM_MKL
Uncertain
0.86
D
LIST_S2
Benign
0.78
T;.;T;T;T
M_CAP
Benign
0.017
T
MetaRNN
Benign
0.055
T;T;T;T;T
MetaSVM
Benign
-0.77
T
PhyloP100
2.8
PrimateAI
Benign
0.32
T
PROVEAN
Benign
-0.090
.;N;.;N;N
REVEL
Benign
0.14
Sift
Benign
0.52
.;T;.;T;T
Sift4G
Benign
0.32
T;T;T;T;T
Polyphen
0.0050, 0.013
.;B;.;.;B
Vest4
0.33
MVP
0.63
MPC
0.017
ClinPred
0.044
T
GERP RS
5.1
gMVP
0.35
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs145064612; hg19: chrX-32716024; API